Advances in Schizophrenia Research 2009 (Record no. 110272)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05724nam a22004935i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-1-4419-0913-8 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220084503.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 100301s2010 xxu| s |||| 0|eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781441909138 |
| -- | 978-1-4419-0913-8 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-1-4419-0913-8 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RC434.2-574 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MMH |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED105000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 616.89 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Gattaz, Wagner F. |
| Relator term | editor. |
| 245 10 - TITLE STATEMENT | |
| Title | Advances in Schizophrenia Research 2009 |
| Medium | [electronic resource] / |
| Statement of responsibility, etc | edited by Wagner F. Gattaz, Geraldo Busatto. |
| 264 #1 - | |
| -- | New York, NY : |
| -- | Springer New York, |
| -- | 2010. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | XX, 408p. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Epidemiology And Risk Factors -- Incidence and Outcome of Schizophrenia Across the Globe -- Gene–Environment Interactions for Searchers: Collaboration between Epidemiology and Molecular Genetics -- The Natural History of the Course and Outcome of Schizophrenia -- Impact of Contextual Environmental Mechanisms on the Incidence of Schizophrenia and Other Psychoses -- Pathophysiology -- Disinhibition of Prefrontal Cortex Neurons in Schizophrenia -- Brain Anatomical Abnormalities in Schizophrenia: Neurodevelopmental Origins and Patterns of Progression over Time -- The Neuropathology of Schizophrenia: Central Role for the Hippocampus? -- Molecular Neuroimaging, Pathophysiological Mechanisms, and Drug Discovery -- Genetics -- Animal Models of Schizophrenia: Focus on Hippocampal Disruption of Dopamine System Regulation -- Genetic and Proteomic Studies in Schizophrenia -- Neurogenetic Risk Mechanisms of Schizophrenia: An Imaging Genetics Approach -- Progress in Genetic Studies of Schizophrenia -- Psychopathology, Cognition, Outcome -- Prediction of Psychosis Through the Prodromal Syndrome -- Schizophrenia as a Cognitive Disorder: Recent Approaches to Identifying its Core Cognitive Components to Aid Treatment Development -- Cognitive and Social Processes in Psychosis: Recent Developments -- The Impact of Early Intervention in Schizophrenia -- The Cross-Sectional and Longitudinal Architecture of Schizophrenia: Significance for Diagnosis and Intervention? -- Schizophrenia and Other Psychotic Disorders: Boundaries and Similarities -- Continua or Classes? Vexed Questions on the Latent Structure of Schizophrenia -- Integrating the Epidemiology and Pathogenesis of Schizophrenia from the Street to the Striatum: Integrating the Epidemiology and Pathogenesis of Schizophrenia -- Cannabis: A Clue or a Distraction in the Search for ‘Causes’ of Psychosis? -- The ‘Totality’ of Psychosis: Epidemiology and Developmental Pathobiology -- Treatment -- Comparative Efficacy and Safety of First - and Second-Generation Antipsychotics in the Treatment of Schizophrenia: Facts and Fiction -- Long-Acting Antipsychotic Medication and the Outcome of Schizophrenia -- Modern Community Care Strategies for Schizophrenia Care: Impacts on Outcome -- Does Stigma Impair Treatment Response and Rehabilitation in Schizophrenia? The “Contribution” of Mental Health Professionals -- Treatment of Schizophrenia: Discussion. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | Advances in Schizophrenia Research 2009 Edited by Wagner F. Gattaz and Gerardo Busatto Schizophrenia stands as a major psychiatric mystery: devastating to patients and families, resistant to treatment, burdened by stigma, causes unknown. As interest and research in the disorder continue worldwide, new sources for comprehensive reviews of cutting-edge studies are of growing importance. The leadoff volume of Advances in Schizophrenia Research 2009 fills this need with welcome innovation and scientific rigor. Presenting papers from the recent Symposium on the Search for the Causes of Schizophrenia, leading scientists offer latest findings, promising theories, relevant controversies, and emerging frontiers, in areas as varied as commonalities with other psychotic disorders and the impact of social factors on rehabilitation. Whether one’s interest is in prevalence, genetics, risk factors, neuropathology, diagnostic boundaries, or treatment options, the discussion includes a number of intriguing and informative perspectives. A sampling of the topics covered: Incidence and outcome of schizophrenia: the view from around the world. Schizophrenia: neurodevelopmental, neurodegenerative, or both? The molecular genetics and proteomics of schizophrenia. Marijuana use: distraction from the issues, or key to the disease? Antipsychotic drug treatment: facts and fiction The case for schizophrenia as cognitive disorder. This wide-ranging coverage makes Advances in Schizophrenia Research 2009 a reference for professionals in clinical psychology, psychiatry, neuropsychology and other mental health workers, promoting more nuanced understanding of the disease, providing deeper insights into its management, and inspiring new possibilities for practice and research. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychiatry. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychology, clinical. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Consciousness. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Psychiatry. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Personality and Social Psychology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neurology. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neuropsychology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Busatto, Geraldo. |
| Relator term | editor. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9781441909121 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-1-4419-0913-8 |
| 912 ## - | |
| -- | ZDB-2-SME |
No items available.